The 12 closest competitors and alternatives to Infinity Bio, Inc. among healthcare technology systems companies — ranked by similarity to what Infinity Bio, Inc. actually does, not by market-cap band.
Subscribe to see Infinity Bio, Inc.’s full profile → the full roster, investors in every round, weekly hiring history and every corporate event
Infinity Bio, Inc. is a biotechnology research company that provides detailed insights into the immune system utilizing its proprietary antibody reactome profiling platform.
Infinity Bio, Inc. is a healthcare technology systems company headquartered in United States. Its most recent funding round, Series A, raised $8M in June 2025. Xcout tracks 17 named people at Infinity Bio, Inc., including Joy M Nassif (Chief Executive Officer).
11 more named people on record for Infinity Bio, Inc., with roles, board committees and tenure — see the full roster →
Every round on record:
| Date | Round | Amount | Investors |
|---|---|---|---|
| Series A | $8M | 1 named | |
| SEC Form D filing | $2M | — | |
| SEC Form D filing | $4.5M | — |
Who invested in each round, lead investors, valuations and the co-investor graph — open the full funding history →
Ranked by semantic similarity — how close each company is to Infinity Bio, Inc. by what it does, using Xcout's live company graph. Click any company for its full profile, or its competitor set.
Biotechnology
Impact Proteomics provides a proprietary antigen profiling and protein identification platform that analyzes patient samples to map disease-associated antigens without cloned intermediates. The company serves biotechnology and diagnostic partners by enabling target discovery, companion diagnostics development, and therapeutic selection for oncology and autoimmune diseases.
Biotechnology
Adaptive Biotechnologies Corp. is a biotechnology company headquartered in Seattle, Washington, United States. The firm focuses on decoding and analyzing the human immune system to address various diseases.
Biotechnology
Olink Proteomics provides high-throughput protein biomarker analysis products, instruments, software, and analysis services for life science research and drug development. Utilizing its proprietary Proximity Extension Assay (PEA) technology and next-generation sequencing, the company serves researchers and pharmaceutical organizations focused on biomarker discovery and precision medicine.
Biotechnology
FBB Biomed, Inc. provides an RNA analytics platform that uses blood RNA-seq data to quantify real-time gene activity and generate biological signatures for chronic diseases. The company serves diagnostic laboratories seeking to offer novel monitoring tests and biopharmaceutical companies needing tools to stratify clinical trial participants and measure individual responses.
Biotechnology
SomaLogic, Inc. is an active biotechnology company headquartered in Boulder, Colorado, specializing in proteomics technology and biomarker discovery.
Biotech
IMU Biosciences is headquartered in London, United Kingdom, and operates in the biotechnology sector. The company develops data platforms and immunological profiling technologies supported by a growing scientific team.
Biotechnology
Intus Biosciences develops proprietary microbiome analysis technology that combines patented science, long-read sequencing, and AI to deliver strain-level resolution of microbial data. The company serves healthcare providers, researchers, and consumers through clinical-grade profiling products like GutID and research partnerships aimed at drug development and biomarker discovery.
Healthcare
GlycanAge is a biotechnology firm headquartered in Newcastle upon Tyne, United Kingdom, that develops science-backed biological age testing products measuring IgG glycans to assess chronic inflammation and lifestyle impacts.
Diagnostics
Edifice Health, Inc., formerly known as IUVE, Inc., is a Silicon Valley-based emerging company headquartered in San Mateo, California. The company specializes in immunological health, focusing on the detection and measurement of systemic chronic inflammation.
Biotech
Alamar Biosciences operates as a commercial-stage proteomics firm, specializing in the highly sensitive, simultaneous identification of various proteins for both scientific research and prospective medical applications. Their integrated platform brings together proprietary instruments, specialized consumables, and unique software, forming a comprehensive, end-to-end solution. This system is designed for accurately quantifying multiple proteins, particularly those present in low concentrations, across a wide array of research and potential clinical uses.
Biotech, Diagnostics
Novigenix is an immuno-transcriptomics and TechBio company that provides precision oncology solutions for biopharmaceutical companies and researchers. It offers LITOseek, an AI-powered liquid biopsy platform that analyzes gene activity in immune cells to support biomarker discovery, therapy development, and patient response monitoring.
Healthcare & Biotechnology
Incite Health Life Sciences, Inc. is a CLIA-certified and CAP-accredited high-complexity clinical laboratory that provides specialized diagnostic testing, including pharmacogenomics, infectious disease screening, and immune system monitoring. The company serves physicians, medical institutions, employers, and clinical trials by utilizing advanced methodologies and data-driven approaches to support early detection, disease monitoring, and personalized medicine.
Search any company we track to see its competitive set.
Paste a short paragraph describing a company or product — we'll find the most similar companies we track, scored 1–100.
Funding, investors, tech stack, hiring signals, leadership and corporate events — for Infinity Bio, Inc.and every competitor above — in one live dashboard.
Subscribe to Xcout Intel →